Xeris Pharmaceuticals
15 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D (NCT04074317) | Xeris Pharmaceuticals | 2019-08-22 |
| Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D (NCT03841526) | Xeris Pharmaceuticals | 2019-08-22 |
| Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery (NCT03770637) | Xeris Pharmaceuticals | 2019-05-10 |
| G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes (NCT03738865) | Xeris Pharmaceuticals | 2018-09-27 |
| Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses (NCT03490942) | Xeris Pharmaceuticals | 2018-03-15 |
| G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes (NCT03439072) | Xeris Pharmaceuticals | 2018-01-23 |
Track Xeris Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.